Novartis passes on $550M option to buy Proteon Therapeutics
March 18, 2014 at 13:19 PM EDT
Swiss pharmaceutical company Novartis AG has declined to exercise a $550 million option agreement to purchase Proteon Therapeutics Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|